Postoperative myocardial damages after hip fracture repair are frequent and associated with a poor cardiac outcome: a three-hospital study

8. Kaiser C, Kuster GM, Erne P et al. Risks and benefits of optimised medical and revascularisation therapy in elderly patients with anginaon-treatment analysis of the TIME trial. Eur Heart J 2004; 25: 1036–42. 9. Claude J, Schindler C, Kuster GM et al. Cost-effectiveness of invasive versus medical management of elderly patients with chronic symptomatic coronary artery disease. Eur Heart J 2004; 25: 2195–203. 10. Stone PH, Thompson B, Anderson V et al. Influence of race, sex, and age on management of unstable angina and non-Q wave myocardial infarction. The TIMI-III registry. JAMA 1996; 275: 1104–12. 11. Collinson J, Flather MD, Fox KAA et al. Clinical outcomes, risk stratification and practice patterns of unstable angina and myocardial infarction without ST elevation: prospective registry of acute ischaemic syndromes in the UK (PRAIS-UK). Eur Heart J 2000; 21: 1450–57. 12. De Gregorio J, Kobayashi Y, Albiero R et al. Coronary artery stenting in the elderly: short-term outcome and long-term angiographic and clinical follow up. J Am Coll Cardiol 1998; 32: 577–83. 13. Maurer MS. Age: a nonmodifiable risk factor? J Coll Cardiol 2003; 42: 1427–8. 14. Bowling A. Ageism in cardiology. BMJ 1999; 319: 1353–5. 15. Graham MM, Ghali WA, Faris PD et al. Survival after coronary revascularisation in the elderly. Circulation 2002; 105: 2378–84. 16. Floyd KC, Jayne JE, Kaplan AV et al. Age-based differences of percutaneous intervention in the drug-eluting stent era. J Interven Cardiol 2006; 19: 381–7. 17. Spertus JA, Kettelkamp R, Vance C et al. Prevalence, predictors, and outcomes of premature discontinuation of thienopyridine therapy after drug-eluting stent placement. Circulation 2006; 113: 2803–9.